Numeric Investors’s Haemonetics HAE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q4
$7.15M Buy
+123,100
New +$6.48M 0.05% 347
2017
Q1
Sell
-26,700
Closed -$1.07M 1061
2016
Q4
$1.07M Sell
26,700
-39,200
-59% -$1.48M 0.01% 642
2016
Q3
$2.39M Buy
65,900
+13,000
+25% +$446K 0.02% 445
2016
Q2
$1.53M Buy
+52,900
New +$1.6M 0.01% 498
2015
Q3
Sell
-12,000
Closed -$496K 1045
2015
Q2
$496K Buy
+12,000
New +$506K 0.01% 679
2015
Q1
Sell
-26,200
Closed -$980K 943
2014
Q4
$980K Buy
26,200
+3,300
+14% +$121K 0.01% 459
2014
Q3
$800K Hold
22,900
0.01% 459
2014
Q2
$808K Buy
22,900
+3,100
+16% +$104K 0.01% 466
2014
Q1
$645K Buy
+19,800
New +$757K 0.01% 531

Other funds holding HAE

Numeric Investors's HAE Position: Q4 2017 in Review

Numeric Investors opened a new position in Haemonetics (HAE) in Q4 2017: 123,100 shares worth $7.15M. The stake represents 0.05% of the portfolio and ranks #347 among its holdings. This is a return to the name: Numeric Investors previously reported a position in HAE as recently as Q4 2016.

Numeric Investors first reported a position in HAE in Q1 2014 and has held it in 9 quarters since. 246 funds tracked by Wall St. Rank hold HAE as of Q4 2017.

  • Numeric Investors held 123,100 shares of Haemonetics worth $7.15M as of Q4 2017.
  • Haemonetics was a new Numeric Investors position in Q4 2017.
  • Haemonetics made up 0.05% of Numeric Investors's portfolio in Q4 2017, its #347 holding.
  • Numeric Investors first reported a position in Haemonetics in Q1 2014 and has held it in 9 quarters since.
  • 246 funds tracked by Wall St. Rank held Haemonetics as of Q4 2017.

Based on Numeric Investors's 13F filing for Q4 2017, filed 14 Feb 2018.